About John Martin
John Martin is a chief executive officer and director at Abcuro.
John Martin first appears on SEC filings in 2023.
Experience
This experience comes from SEC filings. The years are when the filings name John Martin in the role, so the role may have started earlier or lasted longer.
Abcuro, Inc.
Chief Executive Officer and director
2023 – 2026 · Newton, MA
Develops immunotherapies for people with autoimmune diseases and cancer.
Key Colleagues at Startups
The people John Martin works with at each company, as listed on that company's latest Form D.
Abcuro, Inc. · Form D, Aug 13, 2026
Michael Dybbs
Partner, Samsara BioCapital and director
RH
Ron Hunt
Director
Ming Fang
Managing Director, Redmile Group
Mark Pruzanski
Chairman of the Board
Sarah Boyce
Director